1. FDA (2013) Guidance for industry acute bacterial skin and skin structure infections: developing drugs for treatment. https://www.fda.gov/downloads/Drugs/Guidances/ucm071185.pdf. Zugegriffen: 20. Juli 2023
2. Bodmann KF, Grabein B, Kresken M (2020) S2k guideline “calculated parenteral initial treatment of bacterial infections in adults—update 2018”, 2nd updated version: foreword. GMS Infect Dis 8:Doc20
3. Drerup C, Eveslage M, Sunderkoetter C et al (2020) Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J Dtsch Dermatol Ges 18:1417–1424
4. Exarchos G, Metaxa L, Constantinidou A et al (2019) Delayed breast cellulitis following surgery for breast cancer: a literature review. Breast Care (Basel) 14:48–52
5. Gabriel A, Chan V, Caldarella M et al (2023) Cellulite: current understanding and treatment. Aesthet Surg J Open Forum 5:ojad50